KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Debt Ratio (2020 - 2025)

Historic Debt Ratio for Regeneron Pharmaceuticals (REGN) over the last 6 years, with Q4 2025 value amounting to 0.05.

  • Regeneron Pharmaceuticals' Debt Ratio fell 683.15% to 0.05 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.05, marking a year-over-year decrease of 683.15%. This contributed to the annual value of 0.05 for FY2025, which is 683.15% down from last year.
  • Latest data reveals that Regeneron Pharmaceuticals reported Debt Ratio of 0.05 as of Q4 2025, which was down 683.15% from 0.05 recorded in Q3 2025.
  • Regeneron Pharmaceuticals' Debt Ratio's 5-year high stood at 0.11 during Q1 2021, with a 5-year trough of 0.05 in Q4 2025.
  • Moreover, its 5-year median value for Debt Ratio was 0.06 (2023), whereas its average is 0.07.
  • As far as peak fluctuations go, Regeneron Pharmaceuticals' Debt Ratio plummeted by 3249.89% in 2022, and later plummeted by 550.8% in 2025.
  • Quarter analysis of 5 years shows Regeneron Pharmaceuticals' Debt Ratio stood at 0.08 in 2021, then decreased by 12.88% to 0.07 in 2022, then fell by 11.62% to 0.06 in 2023, then fell by 12.33% to 0.05 in 2024, then fell by 6.83% to 0.05 in 2025.
  • Its Debt Ratio was 0.05 in Q4 2025, compared to 0.05 in Q3 2025 and 0.05 in Q2 2025.